The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
Open accessAbstract
The chemokine receptor CXCR4 and its ligand CXCL12 play an important homeostatic function by mediating the homing of progenitor cells in the bone marrow and regulating their mobilization into peripheral tissues upon injury or stress. Although the CXCL12/CXCR4 interaction has long been regarded as a monogamous relation, the identification of the pro-inflammatory chemokine macrophage migration inhibitory factor (MIF) as an important second ligand for CXCR4, and of CXCR7 as an alternative receptor for CXCL12, has undermined this interpretation and has considerably complicated the understanding of CXCL12/CXCR4 signaling and associated biological functions. This review aims to provide insight into the current concept of the CXCL12/CXCR4 axis in myocardial infarction (MI) and its underlying pathologies such as atherosclerosis and injury-induced vascular restenosis. It will discuss main findings from in vitro studies, animal experiments and large-scale genome-wide association studies. The importance of the CXCL12/CXCR4 axis in progenitor cell homing and mobilization will be addressed, as will be the function of CXCR4 in different cell types involved in atherosclerosis. Finally, a potential translation of current knowledge on CXCR4 into future therapeutical application will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Melchionna, R., Porcelli, D., Mangoni, A., Carlini, D., Liuzzo, G., Spinetti, G., Antonini, A., Capogrossi, M. C., & Napolitano, M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2219fje · Cited by 53
Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells
Han, K. H., Hong, K. H., Ko, J., Rhee, K. S., Hong, M., Kim, J., Kim, Y. H., & Park, S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103563 · Cited by 53
Post‐translational and cell type‐specific regulation of CXCR4 expression by cytokines
Brühl, H., Cohen, C. D., Linder, S., Kretzler, M., Schlöndorff, D., & Mack, M. (2003) · European Journal of Immunology · doi:10.1002/eji.200324163 · Cited by 52
Molino, M., Woolkalís, M. J., Prévost, N., Praticò, D., Barnathan, E. S., Taraboletti, G., Haggarty, B., Hesselgesser, J., Horuk, R., Hoxie, J. A., et al. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00110-6 · Cited by 51
Anti‐inflammatory therapy by intravenous delivery of non‐heparan sulfate‐binding CXCL12
O’Boyle, G., Mellor, P., Kirby, J. A., & Ali, S. (2009) · The FASEB Journal · doi:10.1096/fj.09-134643 · Cited by 50
Proulx, C., El‐Helou, V., Gosselin, H., Clément, R., Gillis, M., Villeneuve, L. R., & Calderone, A. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0284-5 · Cited by 49
Hematopoietic Interferon Regulatory Factor 8-Deficiency Accelerates Atherosclerosis in Mice
Döring, Y., Soehnlein, O., Drechsler, M. D., Shagdarsuren, E., Chaudhari, S. M., Meiler, S. U., Hartwig, H., Hristov, M., Koenen, R. R., Hieronymus, T., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.236539 · Cited by 48
Self-citationBasu, S., & Broxmeyer, H. E. (2005) · Blood · doi:10.1182/blood-2004-10-4145 · Cited by 46
Caulfield, J., Fernandez, M., Snetkov, V. A., Lee, T. H., & Hawrylowicz, C. M. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01359.x · Cited by 44
Strategies Beyond Genome-Wide Association Studies for Atherosclerosis
Maouche, S., & Schunkert, H. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.232652 · Cited by 44
Yao, L., Heuser‐Baker, J., Herlea‐Pana, O., Iida, R., Wang, Q., Zou, M., & Barlic‐Dicen, J. (2012) · Stem Cells · doi:10.1002/stem.1256 · Cited by 43
Karshovska, E., Zagorac, D., Zernecke, A., Weber, C., & Schober, A. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03086.x · Cited by 43
Self-citationCD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Timothy, B. C. (2007) · Frontiers in bioscience · doi:10.2741/2800 · Cited by 39
Apostolakis, S. Z., Krambovitis, E., Vlata, Z., Kochiadakis, G. E., Baritaki, S., & Spandidos, D. A. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.04.005 · Cited by 39
Towards the therapeutic use of vascular smooth muscle progenitor cells
Merkulova‐Rainon, T., Broquères-You, D., Kubis, N., Silvestre, J., & Levy, B. I. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs097 · Cited by 35
Kohlhapp, F. J., & Zloza, A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_139-1 · Cited by 35
Jie, W., Wang, X., Zhang, Y., Guo, J., Kuang, D., Zhu, P., Wang, G., & Ao, Q. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00720.x · Cited by 34
Schuh, A., Kroh, A., Konschalla, S., Liehn, E. A., Sobota, R. M., Biessen, E. A. L., Bot, I., Sönmez, T. T., Schober, A., Marx, N., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01539.x · Cited by 33
Self-citationWagner, N., Bierhansl, L., Nöldge‐Schomburg, G., Vollmar, B., & Roesner, J. P. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301783 · Cited by 32
Kiechl, S. J., Laxton, R. C., Xiao, Q., Hernesniemi, J. A., Raitakari, O. T., Kähönen, M. A. P., Mayosi, B. M., Jula, A., Moilanen, L., Willeit, J., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213785 · Cited by 30
Basu, S., & Broxmeyer, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900542 · Cited by 28
Pan, C., Chen, C.-W., Sheu, M., & Wu, C. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.11.008 · Cited by 28
Hamesch, K., Subramanian, P., Li, X., Dembowsky, K., Chevalier, É., Weber, C., & Schober, A. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-07-0453 · Cited by 24
Self-citationTanaka, K., & Sata, M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830dd566 · Cited by 24
Conjugated Linoleic Acid Targets β2 Integrin Expression To Suppress Monocyte Adhesion
de Gaetano, M., Dempsey, E., Marcone, S., James, W. G., & Belton, O. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300990 · Cited by 23
Hara, Y., Kusumi, Y., Mitsumata, M., Li, X., & Fujino, M. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0158-x · Cited by 21
White, D. A., Lu, F. Y., Chan, W., Morand, E. F., Kiriazis, H., Duffy, S. J., TAYLOR, A. J., Dart, A. M., Du, X., & Gao, X. (2013) · PLoS ONE · doi:10.1371/annotation/6e24b7bb-83c7-4887-9621-96b64acfb1c1 · Cited by 21
Role of HIF-1α in proton-mediated CXCR4 down-regulation in endothelial cells
Melchionna, R., Romani, M., Ambrosino, V., D’Arcangelo, D., Cencioni, C., Porcelli, D., Toietta, G., Truffa, S., Gaetano, C., Mangoni, A., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp393 · Cited by 20
The effect of statin therapy withdrawal on monocyte subsets
Jaipersad, A. S., Shantsila, E., Blann, A. D., & Lip, G. Y. H. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12183 · Cited by 17
Li, D., Yan, D., Liu, W., Li, M., Yu, J., Li, Y., Qu, Z., & Ruan, Q. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.01.044 · Cited by 15
Erythromycin-induced CXCR4 expression on microvascular endothelial cells
Takagi, Y., Hashimoto, N., Phan, S. H., Imaizumi, K., Matsuo, M., Nakashima, H., Hashimoto, I., Hayashi, Y., Kawabe, T., Shimokata, K., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90477.2008 · Cited by 15
SDF ‐1 promotes ox‐ LDL induced vascular smooth muscle cell proliferation
Li, L., Zhang, X., Bai, X., & Tong, Q. (2013) · Cell Biology International · doi:10.1002/cbin.10126 · Cited by 12
Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
Liehn, E. A., Radu, E., & Schuh, A. (2013) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x11308040003 · Cited by 7
Transforming Growth Factor Beta-1
Zhao, Y. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.64009-7 · Cited by 7
Cited by
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
CXCR4 signaling in health and disease
Pozzobon, T., Goldoni, G., Viola, A., & Molon, B. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.006 · Cited by 256
Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction
Thackeray, J. T., Derlin, T., Haghikia, A., Napp, L. C., Wang, Y., Ross, T. L., Schäfer, A., Tillmanns, J., Wester, H. J., Wollert, K. C., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.09.008 · Cited by 199
Immunotherapy for cardiovascular disease
Lutgens, E., Atzler, D., Döring, Y., Duchene, J., Steffens, S., & Weber, C. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz283 · Cited by 192
Self-citationVallecillo-García, P., Orgeur, M., vom Hofe-Schneider, S., Stumm, J., Kappert, V., Ibrahim, D. M., Börno, S. T., Hayashi, S., Relaix, F., Hildebrandt, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01120-3 · Cited by 126
Metadata
- Authors
- Döring, Y., Pawig, L., Weber, C., & Noels, H.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2014-06-11
- Volume
- 5
- Pages
- 212-212
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2081077945
- Cited by
- 289
- References
- 234
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
